Risk-adjusted 2-year mortality will be outlier reported in 2023. From 2024, outlier reporting will resume for all of the NBOCA trust/MDT outcomes.

NBOCA has moved into the National Cancer Audit Collaborating Centre and the Royal College of Surgeons of England. Future reporting will use existing national datasets.

New short report aiming to improve the accuracy and robustness of the methodology used to measure rectal surgery volume, as well as exploring patient, institution, and surgeon-level characteristics according to rectal surgery volumes.

NBOCA has published a paper on the impact of completion of adjuvant chemotherapy for stage III colon cancer on 3-year cancer-specific mortality.

NBOCA understands that the COVID-19 pandemic has many implications for the treatment of patients with bowel cancer. Read here how NBOCA will deal with this in its future reporting.

The Clinical Outcomes Publication for the 2019 audit period is now available.

The 2019 Annual Report is now available to view

First submission deadline: 31 October 2019

The 2019 Organisational Survey has now been distributed to all hospital-trusts and MDTs.